Linked Life Data

7893987

Source:http://linkedlifedata.com/resource/pubmed/id/7893987

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7893987rdf:typepubmed:Citationlld:pubmed
pubmed-article:7893987lifeskim:mentionsumls-concept:C0025266lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0019900lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0008148lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0020835lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:7893987lifeskim:mentionsumls-concept:C1550476lld:lifeskim
pubmed-article:7893987pubmed:issue4lld:pubmed
pubmed-article:7893987pubmed:dateCreated1995-4-27lld:pubmed
pubmed-article:7893987pubmed:abstractTextThe significance of chlamydia serum IgG and IgA antibodies was studied, by immunoperoxidase assay, in 210 homosexual men at various stages of HIV infection. Cross sectional analysis of chlamydia IgG antibodies at a titer of > or = 128 indicated a significantly higher prevalence rate among AIDS patients (27.0%) as compared to asymptomatic HIV seronegatives (6.0%) (p = 0.022). The geometric mean titer (GMT) of IgG antibodies to chlamydia was also significantly higher in AIDS patients (106.4) as compared to HIV seronegatives (58.2) (p = 0.022) and persistently asymptomatic HIV seropositives (51.7) (p = 0.05). Chlamydia IgA antibodies did not differ significantly in prevalence and GMT among the various groups.lld:pubmed
pubmed-article:7893987pubmed:languageenglld:pubmed
pubmed-article:7893987pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7893987pubmed:citationSubsetIMlld:pubmed
pubmed-article:7893987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7893987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7893987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7893987pubmed:statusMEDLINElld:pubmed
pubmed-article:7893987pubmed:issn0258-851Xlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:LevyEElld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:DetelsRRlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:SarovIIlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:PhairJJlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:KaslowRRlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:SarovBBlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:SaahA JAJlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:RinaldoC RCRlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:ElsanaSSlld:pubmed
pubmed-article:7893987pubmed:authorpubmed-author:GisnbergHHlld:pubmed
pubmed-article:7893987pubmed:issnTypePrintlld:pubmed
pubmed-article:7893987pubmed:volume8lld:pubmed
pubmed-article:7893987pubmed:ownerNLMlld:pubmed
pubmed-article:7893987pubmed:authorsCompleteNlld:pubmed
pubmed-article:7893987pubmed:pagination593-7lld:pubmed
pubmed-article:7893987pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:meshHeadingpubmed-meshheading:7893987-...lld:pubmed
pubmed-article:7893987pubmed:articleTitleChlamydia specific IgG and IgA serum antibodies in a study of homosexual men at various clinical stages of HIV related disease.lld:pubmed
pubmed-article:7893987pubmed:affiliationVirology Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.lld:pubmed
pubmed-article:7893987pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7893987pubmed:publicationTypeMulticenter Studylld:pubmed